In this issue:
Association of antibiotic exposure with survival in patients with melanoma receiving ICI
Nivolumab + ipilimumab for treatment-naïve metastatic uveal melanoma
Nivolumab + ipilimumab in metastatic uveal melanoma
SN biopsy in patients with melanoma improves the accuracy of staging
Cobimetinib + atezolizumab in BRAF V600 wild-type melanoma
Association of histologic regression with a favourable outcome in stage 1 and stage 2 cutaneous melanoma
Long-term outcomes of Mohs micrographic surgery for invasive melanoma of the trunk and proximal portion of the extremities
Melanoma recurrence patterns and management after adjuvant targeted therapy
Prognostic impact of the extent of ulceration in clinical stage I–II melanoma
Please login below to download this issue (PDF)